Explore 6 court opinions on Pharmaceutical Patents. AI-powered plain English summaries, key holdings, and legal analysis.
6 recent cases analyzed in this topic area.
Appeals Court Affirms Non-Infringement Ruling in Patent Dispute Over Dwarfism Drug
This case involves a patent dispute between Ascendis Pharma A/S and Biomarin Pharmaceutical Inc. regarding a drug used to treat achondroplasia, a form of dwarfism. Ascendis sued Biomarin, alleging tha...
Federal Circuit Affirms Patentability of Method of Treatment Claim
Colage v. Collins, decided by Federal Circuit on December 3, 2025, resulted in a plaintiff win outcome. The case concerns the patentability of a "method of treatment" claim for a patented drug. The Fe...
Federal Circuit Affirms Patent Invalidity for Erectile Dysfunction Drug
Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals Inc., decided by Federal Circuit on September 23, 2025, resulted in a defendant win outcome. The core dispute involved the validity of a patent...
CAFC Affirms Non-Infringement Finding in MS Drug Patent Case
Acorda Therapeutics, Inc. v. Alkermes Plc, decided by Federal Circuit on July 25, 2025, resulted in a defendant win outcome. The Federal Circuit affirmed the district court's grant of summary judgment...
Federal Circuit Affirms Patent Infringement for Schizophrenia Treatment
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., decided by Federal Circuit on July 8, 2025, resulted in a plaintiff win outcome. The core dispute centered on whether Teva Pharmaceutic...
Federal Circuit Upholds Merck's Januvia Patent Against Obviousness Challenge
Merck Sharp & Dohme B v. v. Aurobindo Pharma USA, Inc., decided by Federal Circuit on March 13, 2025, resulted in a defendant win outcome. The core dispute centered on whether Merck's patent for its b...